secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cellectar Biosciences, Inc. (CLRB)
CIK:        0001279704
Form:       8-K/A
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001104659-23-072483
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cellectar Biosciences corrects adjourned annual meeting to virtual, reconvenes June 23
--------------------------------------------------------------------------------

- Adjourned 2023 annual meeting reconvenes Friday, June 23, 2023 at 10:00 AM ET via virtual platform.
- Correction from original filing: meeting will be held virtually, not at company headquarters.
- Stockholders as of April 25, 2023 can attend, vote, and submit questions online using control number.
- Proposals to be voted on unchanged from prior proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1279704/000110465923072483/0001104659-23-072483-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1279704/000110465923072483/tm2319110d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-072483

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer